Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Sparta acquires rights to PZG

Dec. 10, 1997

No Comments

TH-9507 proceeds to toxicological studies

Dec. 10, 1997

No Comments

BioTime reports preliminary phase III data from Hextend trial

Dec. 9, 1997

No Comments

Lilly discovers highly potent and selective NPY Y1 receptor antagonists

Dec. 9, 1997

No Comments

NPS and SmithKline Beecham sign additional extension of osteoporosis agreement

Dec. 9, 1997

No Comments

HMR begins phase II trial with GA-EPO

Dec. 8, 1997

No Comments

Sanofi in-licenses antidiabetic drug from Bayer

Dec. 4, 1997

No Comments

New inhibitor of inflammatory bone resorption presented at Tokyo congress

Dec. 4, 1997

No Comments

Vitronectin receptor antagonists described by Hoechst

Dec. 4, 1997

No Comments

Bayer develops CETP inhibitors

Dec. 4, 1997

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Endocrine/metabolic
RSS

Sparta acquires rights to PZG

TH-9507 proceeds to toxicological studies

BioTime reports preliminary phase III data from Hextend trial

Lilly discovers highly potent and selective NPY Y1 receptor antagonists

NPS and SmithKline Beecham sign additional extension of osteoporosis agreement

HMR begins phase II trial with GA-EPO

Sanofi in-licenses antidiabetic drug from Bayer

New inhibitor of inflammatory bone resorption presented at Tokyo congress

Vitronectin receptor antagonists described by Hoechst

Bayer develops CETP inhibitors

Today's news in brief

Today's news in brief

Enhanced Cognition: Lewy body dementia phase II pumps stock

Second insulin receptor offers new therapeutic avenues

Experimental mRNA gene therapy suppresses preeclampsia in mice

Endocrine/metabolic RSS

Endocrine/metabolic
RSS